Longitudinal pharmacoepidemiological and health services research for substance users in treatment: the Belgian TDI-IMA linkage
The Belgian TDI-IMA-database links two separate databases: the Treatment Demand Indicator (TDI) and the database of the Intermutualistic Agency (IMA). The Treatment Demand Indicator is measuring incidence of people with substance use disorders entering drug treatment. The IMA-database covers data, collected in the framework of the compulsory Belgian health care and benefits insurance program, on reimbursed medication and the use of reimbursed health services. The linkage results in pharmacoepidemiological and health service data for people who were in treatment for substance use disorders and for a group of comparators.
The TDI-database was linked to the IMA-database for the period between 01/01/2008 and 31/12/2017, based on the national identification number of patients who have been in alcohol or drug treatment between 01/01/2011 and 31/12/2014. Through this linkage, pharmacoepidemiological and health service data became available for at least three years before the first registered episode in the TDI-database till at least three years after the first episode. For each person in TDI four comparators, who were not in specialized treatment, were matched on age, sex and place of residence.
The TDI-IMA-database allows for an analysis of health seeking behavior and health care pathways of people before and after they entered specialized alcohol and drug treatment.
Van Baelen, L., De Ridder, K., Antoine, J., & Gremeaux, L. (2018). Utilization of gabapentin by people in treatment for substance use disorders in Belgium (2011–2014): a cross-sectional study. Archives of Public Health, 76(1), 17.
Van Baelen, L., De Ridder, K., Antoine, J., & Gremeaux, L. (2018). Longitudinal pharmacoepidemiological and health services research for substance users in treatment: protocol of the Belgian TDI-IMA linkage. Archives of Public Health, 76(1), 3.
Van Baelen L., Antoine J, De Ridder K, Muyldermans G., Gremeaux L. (2019). Diagnostic hepatitis C testing of people in treatment for substance use disorders in Belgium between 2011 and 2014: a cross-sectional study. Acta Gastroenterologica Belgica, 1
Van Baelen L.., Antoine J, De Ridder K, Plettincks E, Gremeaux L. (2019) Mortality of people in treatment for substance use disorders in Belgium between 2011 and 2014: a cross sectional study. Journal of Substance Use, DOI: 10.1080/14659891.2019.1604841
Online artikels & rapporten
Datum laatste wijziging: 20/08/2019
Dit item aanpassen